Cell Derivation and Maintenance Core
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1P01AI175399-01A1
Grant search
Key facts
Disease
COVID-19Start & end year
20242029Known Financial Commitments (USD)
$329,033Funder
National Institutes of Health (NIH)Principal Investigator
PROFESSOR Estelle Cormet-BoyakaResearch Location
United States of AmericaLead Research Institution
OHIO STATE UNIVERSITYResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Post acute and long term health consequences
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
CORE 4 - SUMMARY COVID-19 remains a worldwide health threat. While some people recover quickly and have mild/no symptoms, at least one third develop long-term symptoms referred to as Long-COVID. In order to identify new therapeutic targets this Program will decipher the role of specific pathways and identify the cell-types that control inflammation and virus virulence. The "Cell Derivation and Maintenance Core" or Core 4 will support this Program by providing primary human and/or mouse airway epithelial cells, immune cells, endothelial cells, and cells isolated from the brain. This core will also provide blood as well as fixed brain and lung tissues from patients non-infected and infected with SARS-CoV-2. This core will support Projects 1-3 and will also provide primary airway cells to Core 3.